A woman in her 30s presented with gradually worsening abdominal pain and was found to have hyponatremia. A glioma of the optic chiasm was treated 20 years prior with chemotherapy and radiation. Sequelae included chronic headaches, anterior hypopituitarism, and hydrocephalus necessitating a ventriculoperitoneal shunt. Medications included analgesics, cyclobenzaprine, sumatriptan, ondansetron, divalproex sodium, gabapentin, furosemide, somatotropin, potassium chloride, vitamin D, and estrogen. Haloperidol was recently added. Blood pressure was 125/87 mm Hg. Mucosae were moist and jugular venous pressure was not well seen. Her cardiopulmonary and abdominal examinations were normal, peripheral edema was absent, and sensorium was clear. Table 1 shows initial laboratory data.
Table 1. Laboratory Values.
| Test | Patient's Value | Reference Range |
|---|---|---|
| Plasma | ||
| Sodium, mEq/L | 122 | 136-145 |
| Potassium, mEq/L | 4.3 | 3.4-5.0 |
| Total CO2, mEq/L | 26 | 21-32 |
| Blood urea nitrogen, mg/dL | 7 | 6-20 |
| Creatinine, mg/dL | 0.7 | 0.60-1.10 |
| Glucose, mg/dL | 66 | 60-99 |
| Osmolality, mOsm/kg | 251 | 285-295 |
| Hemoglobin, g/dL | 11.0 | 12-16 |
| Hematocrit, % | 31.8 | 36.0-46.0 |
| Urine | ||
| Osmolality, mOsm/kg | 410 | Varies |
| Sodium, mEq/L | 138 | Varies |
| Potassium, mEq/L | 21 | Varies |
SI conversion factors: to convert blood urea nitrogen to mmol/L, multiply by 0.357; creatinine to μmol/L, multiply by 88.4; glucose to mmol/L, multiply by 0.0555.
Test Characteristics
A low plasma or serum sodium concentration usually indicates an excess of water relative to total body sodium and potassium. Thus, hyponatremia is a measure of water imbalance.1 Plasma sodium concentration measurements can be unreliable in the presence of severe hyperlipidemia or hyperproteinemia (pseudohyponatremia). When plasma has large amounts of other osmotically active organic solutes (eg, glucose or mannitol), true hyponatremia can occur even if the plasma is hypertonic. Therefore, in the presence of hyponatremia, hypotonicity can be confirmed by measuring plasma osmolality. Assessing the extracellular fluid volume is next undertaken to narrow the differential diagnosis. Finally, urine chemistry values can help identify the etiology and guide management (Table 2).
Table 2. Characteristics of Types of Hyponatremia.
| Type of Hyponatremia | ||||||
|---|---|---|---|---|---|---|
| Pseudohyponatremia | Hypertonic | Hypotonic, Subtypea | ||||
| Hypovolemic | Euvolemic | Hypervolemic | ||||
| Plasma osmolality | Normal | High | Low | Low | Low | |
| Causes | Hyperlipidemia, multiple myeloma | Hyperglycemia, mannitol | Salt loss (gastrointestinal, skin, or urinary, primary adrenal insufficiency, diuretics) | SIADH, secondary adrenal insufficiency, severe hypothyroidism | Primary polydipsia, low solute intake | Liver cirrhosis, heart failure |
| Physical examination | NA | NA | Tachycardia, hypotension, dry mucous membranes | Euvolemia on physical examination | Edema, signs of underlying disease | |
| Urine osmolality, mOsm/kg | >100 | >100 | >100 | >100 | <100 | >100 |
| Urine sodium, mEq/L | ≥30 | ≥30 | <30 | ≥30 | Varies | <30 |
Abbreviations: NA, not applicable; SIADH, syndrome of inappropriate antidiuretic hormone.
When the blood urea nitrogen concentration is elevated, hypotonic hyponatremia can occur despite normal or elevated measured osmolality. In this case, effective osmolality should be estimated, as described.2
Failure to excrete excess water generally results from an inability to suppress secretion of arginine vasopressin (antidiuretic hormone, ADH) and/or a decrease in effective arterial blood volume (EABV). Transient vasopressin increases may be triggered by pain, nausea, or the postoperative state. Persistent increases in vasopressin levels occur in the syndrome of inappropriate antidiuretic hormone secretion (SIADH; alternatively, the syndrome of antidiuresis2) or with certain medications, commonly fluoxetine or sertraline, carbamazepine, vincristine, or cyclophosphamide.2 Hypovolemic and hypervolemic disorders (eg, heart failure or cirrhosis) often decrease EABV and increase vasopressin levels.3 Decreased EABV in these disorders stimulates sodium and water reabsorption along the proximal nephron, reducing delivery to the diluting segment (the thick ascending limb of the Henle loop and the distal convoluted tubule). Normally, sodium chloride reabsorption in the thick ascending limb of the Henle loop and the distal convoluted tubule produces dilute tubular fluid necessary for water excretion. Reduced distal delivery of sodium limits the volume of electrolyte-poor urine that can be generated. Hyponatremia from reduced EABV (ie, hypovolemic or hypervolemic but not euvolemic) is characterized by low urinary sodium concentration (eg, <30 mEq/L),2 reflecting the increased proximal tubular sodium reabsorption (Table 2). Hypervolemic hyponatremia caused by renal failure is identified by abnormal creatinine.
According to 2014 Medicare data,4 national fee limits for plasma and urine sodium and osmolality testing are each less than $10.
Application of Test Result to This Patient
The low plasma sodium concentration suggested relative water excess, which was confirmed by the low plasma osmolality. Physical examination was consistent with euvolemia because of no primary features establishing hypervolemia, peripheraledema, ascites, or hypovolemia. In euvolemic hyponatremia, the distribution of excess water is shared between the extracellular compartment and the much larger intracellular compartment, so edema is not present. Rarely, massive water intake causes hyponatremia by overwhelming a normal urinary diluting mechanism; this is characterized by maximally dilute urine (eg, urineo smolality <100 mOsmol/kg). In this case, the urine osmolality was not maximally dilute, indicating an inappropriate renal response to the water excess. The absence of a urine sodium level of less than 30 mEq/L corroborated the assessment of euvolemia.2 Therefore, this patient has euvolemic hypotonic hyponatremia. The etiology is likely SIADH attributable to the haloperidol or a central nervous system lesion.
What Are the Alternative Diagnostic Approaches?
Plasma sodium concentration and osmolality are the only laboratory measures for detecting water excess or deficit. Occasionally, secondary adrenal insufficiency or severe hypothyroidism can produce euvolemic hypotonic hyponatremia, and tests of thyroid and adrenal function can be ordered. Either test might show abnormal results in this individual with known hypopituitarism.
Patient Outcome
Because the patient was minimally symptomatic, she was treated with fluid restriction and haloperidol was discontinued. However, her plasma sodium concentration declined further. When the sum of the urine sodium and potassium is lower than the plasma sodium level, the patient is excreting electrolyte-free water and should improve if fluid intake is 1 L per day or less and urine flow is adequate (>1.5 L/d). If the sum of the urine sodium and potassium exceeds the plasma sodium level, as in this case, hyponatremia may worsen, despite fluid restriction, unless the underlying disorder is corrected.5 The patient therefore required oral sodium chloride, which resulted in a gradual increase in the plasma sodium concentration.6
Clinical Bottom Line.
Hyponatremia is a measure of water imbalance.
In the presence of hyponatremia, hypotonicity is confirmed by a plasma osmolality value of less than 270 mOsm/kg.
True (ie, hypotonic) hyponatremia usually results from elevated antidiuretic hormone or decreased effective arterial blood volume.
Hyponatremia due to reduced effective arterial blood volume is characterized by a urinary sodium concentration <30 mEq/L.
How Do You Interpret These Test Results?
The patient has hypovolemic hypotonic hyponatremia.
The patient has euvolemic hypotonic hyponatremia.
The patient has hypervolemic hypertonic hyponatremia.
The patient has hypervolemic hypotonic hyponatremia.
Answer
B. The patient has euvolemic hypotonic hyponatremia.
Footnotes
Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Ellison and Cohen report receipt of grants from the National Institutes of Health and the Department of Veterans Affairs during the conduct of the study; and personal fees from AstraZeneca outside the submitted work.
References
- 1.Edelman IS, Leibman J, O'Meara MP, et al. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37(9):1236–1256. doi: 10.1172/JCI103712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ellison DH, Berl T. Clinical practice: the syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–2072. doi: 10.1056/NEJMcp066837. [DOI] [PubMed] [Google Scholar]
- 3.Anderson RJ, Chung HM, Kluge R, et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102(2):164–168. doi: 10.7326/0003-4819-102-2-164. [DOI] [PubMed] [Google Scholar]
- 4. [Accessed March 7, 2015];Healthcare Bluebook. 2014 https://healthcarebluebook.com/
- 5.Furst H, Hallows KR, Post J, et al. The urine/plasma electrolyte ratio. Am J Med Sci. 2000;319(4):240–244. doi: 10.1097/00000441-200004000-00007. [DOI] [PubMed] [Google Scholar]
- 6.Kerns E, Patel S, Cohen DM. Hourly oral sodium chloride for the rapid and predictable treatment of hyponatremia. Clin Nephrol. 2013;82(12):397–401. doi: 10.5414/CN108014. [DOI] [PMC free article] [PubMed] [Google Scholar]
